https://www.zacks.com/stock/news/2198021/the-pennant-group-inc-pntg-now-trades-above-golden-cross-time-to-buy?cid=CS-ZC-FT-tale_of_the_tape|golden_crossover-2198021
Dec 14, 2023 - Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
zc:1393620019917152544
0
https://www.zacks.com/stock/news/2198022/bears-are-losing-control-over-gain-therapeutics-inc-ganx-here-s-why-it-s-a-buy-now?cid=CS-ZC-FT-tale_of_the_tape|hammer_chart_pattern_(ta)-2198022
Dec 14, 2023 - After losing some value lately, a hammer chart pattern has been formed for Gain Therapeutics, Inc. (GANX), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
zc:-8429597459200296513
0
https://www.zacks.com/stock/news/2197991/are-investors-undervaluing-ingredion-ingr-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2197991
Dec 14, 2023 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
zc:-5175621217131274788
0
https://www.zacks.com/stock/news/2197993/is-cna-financial-cna-stock-undervalued-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2197993
Dec 14, 2023 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
zc:-8199104735369608552
0
https://www.zacks.com/stock/news/2197994/are-investors-undervaluing-arcos-dorados-arco-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2197994
Dec 14, 2023 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
zc:3118852388178928422
0
https://www.zacks.com/stock/news/2197998/are-investors-undervaluing-casey-s-general-stores-casy-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2197998
Dec 14, 2023 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
zc:5900762410350150048
0
https://www.zacks.com/stock/news/2197872/here-s-why-hold-strategy-is-apt-for-valero-vlo-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2197872
Dec 14, 2023 - Valero's (VLO) premium refining operations are resilient, even when the business operating environment is carbon-constrained.
zc:-5243305895340655651
0
https://www.zacks.com/stock/news/2197859/if-you-invested-1000-in-a-o-smith-a-decade-ago-this-is-how-much-it-d-be-worth-now?cid=CS-ZC-FT-tale_of_the_tape|investing_$1000-2197859
Dec 14, 2023 - Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
zc:6697011903901603032
0
https://www.zacks.com/stock/news/2197789/here-s-why-you-should-retain-glaukos-gkos-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2197789
Dec 14, 2023 - Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.
zc:-7083492783214608106
0
https://www.zacks.com/stock/news/2197779/reasons-to-add-american-states-water-awr-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2197779
Dec 14, 2023 - American States Water (AWR) makes a strong case for investment, given its growth prospects, strong ROE and capability to increase shareholders' value.
zc:-7241220124788769549
0